Vitrafy Life Sciences Ltd (vfy) Logo

Vitrafy Life Sciences Ltd (VFY)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

VFY ASX Chart

Snapshot

Vitrafy Life Sciences Limited (VFY) has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets (>88% recovery vs >50% industry standard), cell & gene therapies (96% viability vs 70% industry minimum), aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +97.60%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 851 of 2,337
Sector Rank 53 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OCC / OIL / EMV
EPS $0.145
DPS $0.00
Book Value Per Share $0.287

Broker Consensus

VFY is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.vitrafy.com
Registry Xcend Pty Ltd
Auditor Grant Thornton Audit Pty Ltd
Date Listed 26 Nov 2024

Upcoming Calendar (Forecasted)

Date Event
04/08/2026 Report (Prelim)
04/08/2026 Report (Annual)
03/02/2027 Report (Interim)

Former Company Names

  • Vitrafy Life Sciences Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

VFY directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/02/26 Leigh Farrell Buy +15,311 $1.71 $26,120 On-market trade
15/12/25 Brent Owens Issued 275,346 $1.43 $395,121 Issue of securities
20/11/25 Kathryn(Kate) Munnings Expiry 833,777 $1.40 $1,167,287 Options expired
29/08/25 John McBain Buy +13,433 $1.35 $18,134 On-market trade
28/08/25 John McBain Buy +23,567 $1.34 $31,657 On-market trade
18/03/25 John McBain Buy +28,255 $1.36 $38,435 On-market trade
10/12/24 John McBain Buy +27,500 $1.80 $49,461 On-market trade

Director Interests

The current holdings of VFY directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Leigh Farrell 19/02/2026 0 15,311 N/A N/A
Jeannie(Jeannette) Joughin 20/01/2026 0 N/A N/A N/A
Kathryn(Kate) Munnings 20/11/2025 N/A 294,973 952,888 N/A
Brent Owens 30/06/2025 N/A 1,918,040 2,639,295 N/A
Vaughan Webber 30/06/2025 N/A 195,776 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jul 30, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Stacey Inv Aust Pty Ltd 2,586,957 6.28%
Ryder Capital Management Pty Ltd 1,755,639 4.26%
J P Morgan Nominees Australia Pty Limited 1,566,737 3.80%
Rubino Group Pty Ltd <Rubino Group A/C> 1,432,000 3.48%
Suetone Pty Ltd <The Ak Shadforth Family A/C> 741,580 1.80%
Ryder Capital Limited 724,638 1.76%
Ryder Investment Management Pty Ltd 724,638 1.76%
Krisami Investments Pty Ltd 560,854 1.36%
Three Earls Pty Ltd 545,974 1.33%
Fifty Second Celebration Pty Ltd <Mcbain Family A/C> 543,476 1.32%
Fir Nominees Pty Limited <Trs A/C> 519,134 1.26%
Ubs Nominees Pty Ltd 514,537 1.25%
Rowena House Pty Ltd 511,246 1.24%
Telunapa Pty Ltd <Telunapa Capital A/C> 468,017 1.14%
Bungeeltap Pty Ltd 464,086 1.13%
Thorney Technologies Limited 434,782 1.06%
Tiga Trading Pty Ltd <Tiga A/C> 362,319 0.88%
Tigganpan Pty Ltd 362,319 0.88%
Banleigh Pty Ltd <Michael Gronow Fam S/F A/C> 344,385 0.84%
Mr Michael Kenneth Harvey & Mr Bruce William Neill & Ms Brooke Elizabeth Slattery 331,086 0.80%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 104 236 173 366 131 1,010

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Ryder Capital Limited 30/07/2025 4,126,462 6.40
Ryder Capital Limted and associated entities 15/01/2026 4,825,839 7.56

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
15-01-26 Ryder Capital Limted and associated entities 699,377 6.46 7.56

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $1.50 30 June
VFY Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.